Tapinarof Completed Phase 3 Trials for Psoriasis Vulgaris (Plaque Psoriasis) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03956355Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)
NCT03983980Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)